Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss of $1.13/sh
Tweet
Share
E-mail
Get Alerts VRDN Hot Sheet
Join SI Premium – FREE
Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q4 EPS of ($1.13), versus $1.31 reported last year. Revenue for the quarter came in at $105 thousand, versus $214 thousand reported last year.
For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
- Idaho Strategic Resources, Inc. (IDR) Misses Q2 EPS by 4c
- 22nd Century Group (XXII) Misses Q2 EPS by 9800c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
